Open-Systems-Pharmacology Fluvoxamine-Model issues

Open-Systems-Pharmacology / Fluvoxamine-Model

Whole-body PBPK model of fluvoxamine as CYP1A2 and CYP3A4 DDI perpetrator drug

0 stars 3 forks source link

issues

Newest

Newest Most commented Recently updated Oldest Least commented Least recently updated

Typo in the project (alt-Version)

#22 Yuri05 opened 2 years ago
0
Update workflows

#21 Yuri05 closed 2 years ago
3
Create release "alt_v1.0"

#20 PavelBal closed 2 years ago
4
14 convert hyperlinks to lower case

#19 Yuri05 closed 2 years ago
0
Open systems pharmacology cyp1a2 cyp2 c19 ddi

#18 PavelBal closed 2 years ago
4
Cyp1a2 cyp2 c19 ddi

#17 PavelBal closed 2 years ago
5
Cyp1a2 cyp2 c19 ddi

#16 PavelBal closed 2 years ago
1
Fluvoxamine report typo

#15 prvmalik closed 2 years ago
1
Convert hyperlinks to lower case

#14 Yuri05 closed 2 years ago
0
Update to PK-Sim 10

#13 AndreDlm closed 3 years ago
1
Workflow.m is missing

#12 Yuri05 closed 2 years ago
0
Cyp1a2 cyp2c19

#11 PavelBal closed 3 years ago
0
Cyp1a2 cyp2c19

#10 PavelBal closed 3 years ago
0
Source of inhibition constant for CYP3A4 not clear

#9 AndreDlm opened 3 years ago
0
Update Section2.2_Data.md

#8 TWendl closed 4 years ago
0
corrections to fluvoxamine evaluation report static content

#7 TWendl closed 4 years ago
0
Adjusts description enzyme inhibition

#6 AndreDlm closed 4 years ago
0
Several editorial updates, references and physicochemical data corrected

#5 AndreDlm closed 4 years ago
0
Several updates static text blocks

#4 AndreDlm closed 4 years ago
0
Source of inhibition constants for CYP1A2 not clear

#3 AndreDlm opened 4 years ago
2
json and evaluation plan files added

#2 AndreDlm closed 4 years ago
1
Update README.md

#1 Yuri05 closed 5 years ago
0